Sensitivity of CD3/CD28-stimulated versus non-stimulated lymphocytes to ionizing radiation and genotoxic anticancer drugs: key role of ATM in the differential radiation response
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sensitivity of CD3/CD28-stimulated versus non-stimulated lymphocytes to ionizing radiation and genotoxic anticancer drugs: key role of ATM in the differential radiation response
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 11, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-15
DOI
10.1038/s41419-018-1095-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AKT2 suppresses pro-survival autophagy triggered by DNA double-strand breaks in colorectal cancer cells
- (2017) Nina Seiwert et al. Cell Death & Disease
- Death of Monocytes through Oxidative Burst of Macrophages and Neutrophils: Killing in Trans
- (2017) Viviane Ponath et al. PLoS One
- The γH2AX DNA damage assay from a drop of blood
- (2016) Daniel Heylmann et al. Scientific Reports
- Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
- (2015) Wan-ting He et al. CELL RESEARCH
- Cytolethal distending toxin (CDT) is a radiomimetic agent and induces persistent levels of DNA double-strand breaks in human fibroblasts
- (2014) Jörg Fahrer et al. DNA REPAIR
- Comprehensive data on ionising radiation from Fukushima Daiichi nuclear power plant in the town of Miharu, Fukushima prefecture: The Misho Project
- (2014) T Koike et al. JOURNAL OF RADIOLOGICAL PROTECTION
- Inhibition of PARP1-dependent end-joining contributes to Olaparib-mediated radiosensitization in tumor cells
- (2014) Annika Kötter et al. Molecular Oncology
- FANCD2 Binds CtIP and Regulates DNA-End Resection during DNA Interstrand Crosslink Repair
- (2014) Junya Unno et al. Cell Reports
- ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
- (2013) L. Biddlestone-Thorpe et al. CLINICAL CANCER RESEARCH
- Adoptive immunotherapy for cancer
- (2013) Marco Ruella et al. IMMUNOLOGICAL REVIEWS
- Combined Treatment Effects of Radiation and Immunotherapy: Studies in an Autochthonous Prostate Cancer Model
- (2013) Satoshi Wada et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Human CD4+CD25+ Regulatory T Cells Are Sensitive to Low Dose Cyclophosphamide: Implications for the Immune Response
- (2013) Daniel Heylmann et al. PLoS One
- Tumor-Infiltrating Immune Cells Promoting Tumor Invasion and Metastasis: Existing Theories
- (2013) Yan-gao Man et al. Journal of Cancer
- DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis
- (2012) Wynand P. Roos et al. CANCER LETTERS
- Temozolomide Dosing Regimens for Glioma Patients
- (2012) Herwig M. Strik et al. Current Neurology and Neuroscience Reports
- Radiation-Induced Formation of 2′,3′-Dideoxyribonucleosides in DNA: A Potential Signature of Low-Energy Electrons
- (2012) Guru S. Madugundu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Adoptive Transfer of Mammaglobin-A Epitope Specific CD8 T Cells Combined with a Single Low Dose of Total Body Irradiation Eradicates Breast Tumors
- (2012) Nadine M. Lerret et al. PLoS One
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
- (2011) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- The Present and Future of Peptide Vaccines for Cancer
- (2011) Craig L. Slingluff CANCER JOURNAL
- Immune microenvironments in solid tumors: new targets for therapy
- (2011) S. L. Shiao et al. GENES & DEVELOPMENT
- Direct effects of ionizing radiation on macromolecules
- (2011) Ellis S. Kempner JOURNAL OF POLYMER SCIENCE PART B-POLYMER PHYSICS
- Temozolomide: Mechanisms of Action, Repair and Resistance
- (2011) Jihong Zhang et al. Current Molecular Pharmacology
- Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery
- (2010) Gregory Driessens et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A positive role for c-Abl in Atm and Atr activation in DNA damage response
- (2010) X Wang et al. CELL DEATH AND DIFFERENTIATION
- Cell Death Mechanisms Induced by Cytotoxic Lymphocytes
- (2010) L Chávez-Galán et al. Cellular & Molecular Immunology
- Combining low-dose cyclophosphamide with GM-CSF–secreting prostate cancer immunotherapy enhances antitumor immune effects
- (2010) Emmanuel S Antonarakis et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effects of Concomitant Temozolomide and Radiation Therapies on WT1-specific T-cells in Malignant Glioma
- (2010) Y. Chiba et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Temozolomide in malignant gliomas: current use and future targets
- (2009) J. Lee Villano et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Radiochemotherapy in the Treatment of Breast Cancer
- (2009) N.S. Bese CLINICAL ONCOLOGY
- Development of risk maps to minimize uranium exposures in the Navajo Churchrock mining district
- (2009) Jamie L deLemos et al. Environmental Health
- Poly(ADP-ribose) signals to mitochondrial AIF: A key event in parthanatos
- (2009) Yingfei Wang et al. EXPERIMENTAL NEUROLOGY
- The T-cell-receptor signaling network
- (2009) M. Huse JOURNAL OF CELL SCIENCE
- Cyclophosphamide and cancer: golden anniversary
- (2009) Ashkan Emadi et al. Nature Reviews Clinical Oncology
- Immune infiltration in human tumors: a prognostic factor that should not be ignored
- (2009) F Pagès et al. ONCOGENE
- Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach
- (2008) Bridget E. McLaughlin et al. CYTOMETRY PART A
- Apoptotic death induced by the cyclophosphamide analogue mafosfamide in human lymphoblastoid cells: Contribution of DNA replication, transcription inhibition and Chk/p53 signaling
- (2008) Michael Goldstein et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started